The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
In utero exposure to mycophenolate mofetil: A characteristic phenotype?
Abstract
Mycophenolate mofetil (MMF) is a widely prescribed immunosuppressive agent after solid organ transplantation. Potential teratogenic effects after in utero exposure to MMF in experimental studies and clinical observations in humans has been postulated in recent literature. However, a specific pattern of malformation has not been identified yet. We present a newborn patient, born to a recipient of renal transplantation, who became pregnant while taking MMF as immunosuppressive therapy. The newborn exhibited cleft lip and palate, bilateral microtia and atretic external auditory canals, chorioretinal coloboma, hypertelorism, and micrognathia. An extensive review of the literature documented six other cases with similar malformations after in utero exposure to MMF. A consistent pattern of malformations comprising cleft lip and palate, microtia and external auditory canals could be observed in five of the six cases. A different malformative pattern observed in one of the patients could be attributed to a different agent rather than MMF. The possible teratogenic effects of other immunosuppressive drugs, such as tacrolimus and prednisone, to which this patient was also exposed, are discussed herein. In addition, the differential diagnosis with other dysmorphic syndromes that can present with a similar phenotype, such as CHARGE syndrome, 18q deletion and hypertelorism‐microtia‐clefting (HMC) syndrome, is presented. We conclude that in utero exposure to MMF can cause a characteristic phenotype and propose the existence of a mycophenolate‐associated embryopathy whose main features are: cleft lip and palate, microtia with atresia of external auditory canal, micrognathia and hypertelorism. Ocular anomalies, corpus callosum agenesis, heart defects, kidney malformations, and diaphragmatic hernia may be part of the phenotypic spectrum of MMF embryopathy. The human teratogenicity of MMF is reinforced by this report, and the current contraceptive recommendations about its use in fertile women are stressed. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sanlaville, D., & Verloes, A. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201778 · Cited by 332
Cited by
Kopp, J. B., Anders, H.-J., Susztak, K., Podestà, M. A., Remuzzi, G., Hildebrandt, F., & Romagnani, P. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0196-7 · Cited by 562
Microtia: Epidemiology and genetics
Luquetti, D. V., Heike, C. L., Hing, A. V., Cunningham, M. L., & Cox, T. C. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34352 · Cited by 457
Safety of dermatologic medications in pregnancy and lactation
Murase, J. E., Heller, M. M., & Butler, D. C. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.09.010 · Cited by 220
Zhang, Q.-G., Zhang, J., Yu, P., & Shen, H. (2009) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0b013e3181b454d8 · Cited by 45
Metadata
- Authors
- Perez‐Aytes, A., Ledo, A., Boso, V., Sáenz, P., Roma, E., Poveda, J. L., & Vento, M.
- Venue
- American Journal of Medical Genetics Part A
- Publisher
- Wiley
- Published
- 2007-12-19
- Volume
- 146A
- Issue
- 1
- Pages
- 1-7
- ISSN
- 1552-4825 (ISSN-L)
- 1552-4833
- OpenAlex
- W2005532552
- Cited by
- 166
- References
- 1
- FWCI
- 13.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In utero exposure to mycophenolate mofetil: A characteristic phenotype? https://app.cochat.ai/papers/10.1002/ajmg.a.32117
- The paper
- Perez‐Aytes, A., Ledo, A., Boso, V., Sáenz, P., Roma, E., Poveda, J. L., & Vento, M. (2008). In utero exposure to mycophenolate mofetil: A characteristic phenotype? American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.32117
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.